CAST, a nonprofit organization headquartered in Wakefield, MA, believes learning should have no limits. Founded in 1984, by education researchers, CAST created the Universal Design for Learning (UDL) framework, a set of principles based on learning sciences including neuropsychology, human development, and education research.

Xylyx Bio spun out of Columbia University’s renowned Laboratory for Stem Cell and Tissue Engineering in 2016 to commercialize matrix bioactives for tissue regeneration and complete cell health.

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions in sport medicine and severe burn cases and is a leader in the development of autologous cell therapies to repair or restore damaged tissues or organs.

Pluristyx was established in 2018 with the goal of solving challenges associated with cell manufacturing by manufacturing GMP grade pluripotent stem cells at large scale for use as a universal starting material for the further manufacturing of therapeutic regenerative medicine products. 

RoosterBio was founded in 2013 to specifically address the industry-wide bottleneck that is the scarcity of high quality and scalable cellular starting materials for product development and clinical manufacturing, is a pioneer in Regenerative Medicine (RM) manufacturing, with a focus on human mesenchymal stem/stromal cells (hMSC) raw materials, bioprocess design, and production technologies.

Sudhin Biopharma is an early-stage Biopharma technology development company located in Superior, CO, founded in 2014 by Prof. Dhinakar Kompala, after taking early retirement from his faculty position in the department of Chemical and Biological Engineering at the University of Colorado, Boulder. 

Trailhead Biosystems, headquartered in Cleveland, Ohio, merges developmental biology and cell therapeutics with cutting edge hardware, computerized experimental design, and analysis to perform process-specific parameter optimization in the development of cell therapies.

AlloSource is a 501(c)3, not-for-profit organization, headquartered in Centennial, Colorado with approximately 500 employees dedicated to advancing the science and use of transplantable allogeneic cells and tissue through pioneering research in regenerative therapies.

ArunA Bio, located in Athens, Georgia, with nearly 20 employees, was founded in 2005 as a developer and manufacturer of human neural-specific cell lines. The company has since transformed into a drug development company with a duel focus platform technology.